Error loading player: No playable sources found

2210

Changing the Status Quo on the Detection and Management of Barrett's Esophagus

Date
May 18, 2024

SOCIETY: AGA Risk stratification and screening of Barrett's esophagus: What's new?

Presentations:

IN BARRETT'S ESOPHAGUS, REFLUX INDUCES FEATURES OF EPITHELIAL-MESENCHYMAL PLASTICITY MEDIATED BY APE/REF-1 REDOX FUNCTION: EVIDENCE FROM STUDIES IN BARRETT'S PATIENTS AND ORGANOIDS
BEYOND TFF3: IDENTIFYING NON-ENDOSCOPIC DNA METHYLATION BIOMARKERS FOR IMPROVED DIAGNOSIS OF BARRETT'S ESOPHAGUS
VALIDATION OF RISK ASSESSMENT TOOLS FOR THE DETECTION OF BARRETT’S ESOPHAGUS IN PATIENTS WITHOUT CHRONIC REFLUX SYMPTOMS
UTILITY OF A MULTI-GENE METHYLATION PANEL TO RISK-STRATIFY PATIENTS WITH BARRETT’S ESOPHAGUS AFTER RADIOFREQUENCY ABLATION
NONENDOSCOPIC DETECTION OF BARRETT'S ESOPHAGUS IN PATIENTS WITHOUT GERD SYMPTOMS
DEVELOPMENT AND VALIDATION OF A MACHINE LEARNING (ML) BASED DECISION-MAKING TOOL TO DETERMINE RISK AND TIMING OF RECURRENCE OF BARRETT’S ESOPHAGUS (BE) NEOPLASIA AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY (EET)

Moderators

Speaker Image for Jennifer Kolb
University of California Los Angeles
Speaker Image for Rehan Haidry
Cleveland Clinic London

Related Products

Thumbnail for Updates in Barrett's Esophagus
Updates in Barrett's Esophagus
LIVE STREAM SESSION This AGA session on Barrett's esophagus will provide a state of the art update on screening, surveillance and endoscopic eradication therapy. Experts in this field will review updated guidelines, discuss knowledge gaps and provide practical advice for the practicing clinicians…